Neurostimulation Devices Market by Device Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others) Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

1.1.Report description

1.2.Key benefits for stakeholders

1.3.Key market segments

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study

2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.2.2.Top winning strategies

3.3.Market dynamics

3.3.1.Drivers

3.3.1.1.Rise in prevalence of neurological disorders

3.3.1.2.Increase in investments in R&D for neurological disorders

3.3.2.Restraints

3.3.2.1.Adverse effects and risks associated with neurostimulation devices

3.3.3.Opportunities

3.3.3.1.Use of neurostimulators for new indications

CHAPTER 4:NEUROSTIMULATION DEVICES MARKET, BY DEVICE TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Spinal Cord Stimulators

4.2.1.Key market trends, growth factors, and opportunities

4.2.2.Market size and forecast, by region

4.2.3.Market analysis, by country

4.3.Deep Brain Stimulators

4.3.1.Key market trends, growth factors, and opportunities

4.3.2.Market size and forecast, by region

4.3.3.Market analysis, by country

4.4.Sacral Nerve Stimulators

4.4.1.Key market trends, growth factors, and opportunities

4.4.2.Market size and forecast, by region

4.4.3.Market analysis, by country

4.5.Vagus Nerve Stimulators

4.5.1.Key market trends, growth factors, and opportunities

4.5.2.Market size and forecast, by region

4.5.3.Market analysis, by country

4.6.Others

4.6.1.Key market trends, growth factors, and opportunities

4.6.2.Market size and forecast, by region

4.6.3.Market analysis, by country

CHAPTER 5:NEUROSTIMULATION DEVICES MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Pain Management

5.2.1.Market size and forecast, by region

5.2.2.Market analysis, by country

5.3.Hearing Loss

5.3.1.Market size and forecast, by region

5.3.2.Market analysis, by country

5.4.Urinary Incontinence

5.4.1.Market size and forecast, by region

5.4.2.Market analysis, by country

5.5.Parkinson's Disease

5.5.1.Market size and forecast, by region

5.5.2.Market analysis, by country

5.6.Epilepsy

5.6.1.Market size and forecast, by region

5.6.2.Market analysis, by country

5.7.Others

5.7.1.Market size and forecast, by region

5.7.2.Market analysis, by country

CHAPTER 6:GLOBAL NEUROSTIMULATION DEVICES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends and opportunities

6.2.2.Market size and forecast, by device type

6.2.3.Market size and forecast, by application

6.2.4.Market size and forecast, by country

6.2.4.1.U.S. market size and forecast, by device type

6.2.4.2.U.S. market size and forecast, by application

6.2.4.3.Canada market size and forecast, by device type

6.2.4.4.Canada market size and forecast, by application

6.2.4.5.Mexico market size and forecast, by device type

6.2.4.6.Mexico market size and forecast, by application

6.3.Europe

6.3.1.Key market trends and opportunities

6.3.2.Market size and forecast, by device type

6.3.3.Market size and forecast, by application

6.3.4.Market size and forecast, by country

6.3.4.1.Germany market size and forecast, by device type

6.3.4.2.Germany market size and forecast, by application

6.3.4.3.France market size and forecast, by device type

6.3.4.4.France market size and forecast, by application

6.3.4.5.UK market size and forecast, by device type

6.3.4.6.UK market size and forecast, by application

6.3.4.7.Italy market size and forecast, by device type

6.3.4.8.Italy market size and forecast, by application

6.3.4.10.Rest of Europe market size and forecast, by device type

6.3.4.11.Rest of Europe market size and forecast, by application

6.4.Asia-Pacific

6.4.1.Key market trends and opportunities

6.4.2.Market size and forecast, by device type

6.4.3.Market size and forecast, by application

6.4.4.Market size and forecast, by country

6.4.4.1.Japan market size and forecast, by device type

6.4.4.2.Japan market size and forecast, by application

6.4.4.3.China market size and forecast, by device type

6.4.4.4.China market size and forecast, by application

6.4.4.5.India market size and forecast, by device type

6.4.4.6.India market size and forecast, by application

6.4.4.7.Australia market size and forecast, by device type

6.4.4.8.Australia market size and forecast, by application

6.4.4.9.Rest of Asia-Pacific market size and forecast, by device type

6.4.4.10.Rest of Asia-Pacific market size and forecast, by application

6.5.LAMEA

6.5.1.Key market trends and opportunities

6.5.2.Market size and forecast, by device type

6.5.3.Market size and forecast, by application

6.5.4.Market size and forecast, by country

6.5.4.1.Brazil market size and forecast, by device type

6.5.4.2.Brazil market size and forecast, by application

6.5.4.3.Saudi market size and forecast, by device type

6.5.4.4.Saudi market size and forecast, by application

6.5.4.5.South Africa market size and forecast, by device type

6.5.4.6.South Africa market size and forecast, by application

6.5.4.7.Rest of LAMEA market size and forecast, by device type

6.5.4.8.Rest of LAMEA market size and forecast, by application

CHAPTER 7:COMPANY PROFILES

7.1.Abbott Laboratories

7.1.1.Company overview

7.1.2.Company snapshot

7.1.3.Operating business segments

7.1.4.Product portfolio

7.1.5.Business performance

7.1.6.Key strategic moves and developments

7.2.Aleva Neurotherapeutics SA

7.2.1.Company overview

7.2.2.Company snapshot

7.2.3.Operating business segments

7.2.4.Product portfolio

7.2.5.Key strategic moves and developments

7.3.Boston Scientific Corporation

7.3.1.Company overview

7.3.2.Company snapshot

7.3.3.Operating business segments

7.3.4.Product portfolio

7.3.5.Business performance

7.3.6.Key strategic moves and developments

7.4.ElectroCore Inc.

7.4.1.Company overview

7.4.2.Company snapshot

7.4.3.Operating business segments

7.4.4.Product portfolio

7.4.5.Business performance

7.5.EndoStim Inc.

7.5.1.Company overview

7.5.2.Operating business segments

7.5.3.Product portfolio

7.6.Medtronic plc

7.6.1.Company overview

7.6.2.Company snapshot

7.6.3.Operating business segments

7.6.4.Product portfolio

7.6.5.Business performance

Source: Corporate Publications and AMR Analysis

7.7.NeuroPace Inc.

7.7.1.Company overview

7.7.2.Company snapshot

7.7.3.Operating business segments

7.7.4.Product portfolio

7.7.5.Key strategic moves and developments

7.8.Nevro Corporation

7.8.1.Company overview

7.8.2.Operating business segment

7.8.3.Product portfolio

7.8.4.Business performances

7.8.5.Key strategic moves and developments

7.9.Neuronetics Inc.

7.9.1.Company overview

7.9.2.Neuronetics: Company Snapshot

7.9.3.Operating business segments

7.9.4.Product portfolio

7.9.5.Business performance

7.9.6.Key strategic moves and developments

7.10.NeuroSigma Inc.

7.10.1.Company overview

7.10.2.Company snapshot

7.10.3.Operating business segments

7.10.4.Product portfolio

7.10.5.Key strategic moves and developments

7.11.Synapse Biomedical Inc.

7.11.1.Company overview

7.11.2.Company snapshot

7.11.3.Operating business segments

7.11.4.Product portfolio

7.11.5.Key strategic moves and developments

TABLE 01.GLOBAL NEUROSTIMULATION DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)

TABLE 02.NEUROSTIMULATION DEVICES MARKET, FOR SPINAL CORD STIMULATORS BY REGION, 2018–2026 ($MILLION)

TABLE 03.NEUROSTIMULATION DEVICES MARKET, FOR DEEP BRAIN STIMULATORS BY REGION, 2018–2026 ($MILLION)

TABLE 04.NEUROSTIMULATION DEVICES MARKET, FOR SACRAL NERVE STIMULATORS BY REGION, 2018–2026 ($MILLION)

TABLE 05.NEUROSTIMULATION DEVICES MARKET, FOR VAGUS NERVE STIMULATORS BY REGION, 2018–2026 ($MILLION)

TABLE 06.NEUROSTIMULATION DEVICES MARKET, FOR OTHERS BY REGION, 2018–2026 ($MILLION)

TABLE 07.GLOBAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2018–2026 ($MILLION)

TABLE 08.NEUROSTIMULATION DEVICES MARKET, FOR PAIN MANAGEMENT, BY REGION, 2018–2026 ($MILLION)

TABLE 09.NEUROSTIMULATION DEVICES MARKET FOR HEARING LOSS, BY REGION, 2018–2026 ($MILLION)

TABLE 10.NEUROSTIMULATION DEVICES MARKET FOR URINARY INCONTINENCE, BY REGION, 2018–2026 ($MILLION)

TABLE 11.NEUROSTIMULATION DEVICES MARKET FOR PARKINSON'S DISEASE, BY REGION, 2018–2026 ($MILLION)

TABLE 12.NEUROSTIMULATION DEVICES MARKET FOR EPILEPSY, BY REGION, 2018–2026 ($MILLION)

TABLE 13.NEUROSTIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)

TABLE 14.GLOBAL NEUROSTIMULATION DEVICES MARKET BY REGION, 2018-2026, ($MILLION)

TABLE 15.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 16.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 17.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)

TABLE 18.U.S. NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 19.U.S. NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 20.CANADA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 21.CANADA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 22.MEXICO NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 23.MEXICO NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 24.EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 25.EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 26.EUROPE NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)

TABLE 27.GERMANY NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 28.GERMANY NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 29.FRANCE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 30.FRANCE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 31.UK NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 32.UK NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 33.ITALY NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 34.ITALY NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 35.REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 36.REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 37.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 38.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 39.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)

TABLE 40.JAPAN NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 41.JAPAN NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 42.CHINA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 43.CHINA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 44.INDIA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 45.INDIA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 46.AUSTRALIA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 47.AUSTRALIA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 48.REST OF ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 49.REST OF ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 50.LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 51.LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 52.LAMEA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)

TABLE 53.BRAZIL NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 54.BRAZIL NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 55.SAUDI NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 56.SAUDI NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 57.SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 58.SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 59.REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)

TABLE 60.REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)

TABLE 61.ABBOTT: COMPANY SNAPSHOT

TABLE 62.ABBOTT LABORATORIES: OPERATING SEGMENTS

TABLE 63.ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 64.Aleva neurotherapeutics: company Snapshot

TABLE 65.ALEVA NEUROTHERAPEUTICS: OPERATING SEGMENT

TABLE 66.ALEVA NEUROTHERAPEUTICS: PRODUCT PORTFOLIO

TABLE 68.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS

TABLE 69.BOSTON: PRODUCT PORTFOLIO

TABLE 70.ELECTROCORE INC: COMPANY SNAPSHOT

TABLE 71.ELCTROCORE: OPERATING SEGMENTS

TABLE 72.ELECTROCORE INC: PRODUCT PORTFOLIO

TABLE 73.ENDOSTIM INC: OPERATING SEGMENT

TABLE 74.ENDOSTIM INC: PRODUCT PORTFOLIO

TABLE 75.MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 76.MEDTRONIC PLC: OPERATING SEGMENTS

TABLE 77.MEDTRONIC: PRODUCT PORTFOLIO

TABLE 78.NEUROPACE INC.: COMPANY SNAPSHOT

TABLE 79.NEUROPACE INC.: OPERATING SEGMENTS

TABLE 80.NEUROPACE INC.: PRODUCT PORTFOLIO

TABLE 81.NEVRO CORPORATION.: OPERATING SEGMENTS

TABLE 82.NEVRO CORPORATION.: PRODUCT PORTFOLIO

TABLE 83.NEURONETICS: OPERATING SEGMENT

TABLE 84.NEURONETICS : PRODUCT PORTFOLIO

TABLE 85.NEUROSIGMA INC: COMPANY SNAPSHOT

TABLE 86.NEUROSIGMA INC COMPANY: PRODUCT SEGMENT

TABLE 87.NEUROSIGMA INC: PRODUCT PORTFOLIO

TABLE 88.SYNAPSE BIOMEDICAL: COMPANY SNAPSHOT

TABLE 89.SYNAPSE BIOMEDICAL: OPERATING SEGMENT

TABLE 90.SYNAPSE BIOMEDICAL: PRODUCT PORTFOLIO